Receive our newsletter – data, insights and analysis delivered to you

COVID-19 Drug Trials Studies

Covid-19Powered by

Coronavirus Drug Tracker

The Coronavirus Company/Drug Tracker lists drugs in all stages of preclinical and clinical development (from discovery through to preregistration) for COVID-19 indication. This list is updated dynamically, based on the GlobalData Pharma Intelligence Center Drugs database.

Development Stage refers to the drug’s current stage of development for COVID-19 indication. A drug may have multiple stages of development for other indications.

To view all pipeline pharmaceuticals for COVID-19 indication including off-label trials of marketed drugs, visit the Coronavirus Clinical Trials Tracker.

In partnership with

Deals trends in the Pharma Technologysector: Q1 2020 – Q3 2021

134,028 Grant

Total Value US$m: 60,915.7
YOY Change: 13.1%

3,904 Venture Financing

Total Value US$m: 109,509.9
YOY Change: 42.8%

3,641 Equity Offering

Total Value US$m: 355,882.8
YOY Change: -15.1%

3,453 Contract Service Agreement

Total Value US$m: 2,203.2
YOY Change: -58.1%

2,650 Partnership

Total Value US$m: 131,497.7
YOY Change: -

1,834 Licensing Agreement

Total Value US$m: 270,088
YOY Change: 11.0%

1,188 Acquisition

Total Value US$m: 391,805.3
YOY Change: -19.2%

710 Private Equity

Total Value US$m: 93,653.2
YOY Change: 78.9%

578 Debt Offering

Total Value US$m: 280,545.4
YOY Change: -40.7%

386 Asset Transaction

Total Value US$m: 84,953.9
YOY Change: 269.5%

127 Merger

Total Value US$m: 10,949.8
YOY Change: 306.2%

Note: Application counts are based on publications. Patent applications which are not published yet are not considered for analysis. Publication may take up to 18 months from the application of patents.

Note: Application counts are based on publications. Patent applications which are not published yet are not considered for analysis. Publication may take up to 18 months from the application of patents.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU